danazol has been researched along with cyclosporine in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (30.00) | 18.2507 |
2000's | 7 (23.33) | 29.6817 |
2010's | 14 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ohno, A; Sugino, N; Tanaka, M | 1 |
Keller, F; Passfall, J; Schuller, I | 1 |
Blatt, J; Burckart, G; Howrie, D; Orlando, S | 1 |
Bachman, WR; Brennan, JK | 1 |
Dodds, WJ | 1 |
Chin, M; Harada, K; Kojima, S; Mugishima, H; Ryo, S; Shichino, H; Shimada, T; Suzuki, T; Takamura, M | 1 |
Ezaki, K; Hirano, M; Ino, T; Okamoto, M; Tsuzuki, M; Yamaguchi, T | 1 |
Borrás-Blasco, J; Conesa-Garcia, V; Gonzalez-Delgado, M; Navarro-Ruiz, J; Peris-Marti, J; Rosique-Robles, JD | 1 |
Chemlal, K; Clauvel, JP; Grange, MJ; Lassoued, K; Wyplosz, B | 1 |
Hibi, S; Kojima, S; Kosaka, Y; Mugishima, H; Ohara, A; Sugita, K; Tsuchida, M; Tsukimoto, I; Yabe, H; Yamamoto, M | 1 |
Adachi, M; Akaike, J; Hayashi, T; Hinoda, Y; Hirayama, T; Imai, K; Kasahara, K; Minami, T; Takahashi, S; Takahashi, T | 1 |
Jing, L; Liu, H; Shao, Z | 1 |
Abrahamsson, B; Forsell, P; Forssén, S; Knutson, L; Lennernäs, H; Nordgren, A; Ohgren, C; Persson, EM | 1 |
Charkoftaki, G; Kytariolos, J; Macheras, P | 1 |
Jalaeikhoo, H; Khajeh-Mehrizi, A | 1 |
Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y | 1 |
Bose, P; Khadwal, A; Khurana, H; Lad, D; Malhotra, P; Prakash, G; Sachdeva, MU; Varma, N; Varma, S; Yanamandra, U | 1 |
2 review(s) available for danazol and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Possible cyclosporin-danazol interaction in a patient with aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Danazol; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Inactivation, Metabolic; Male | 1999 |
2 trial(s) available for danazol and cyclosporine
Article | Year |
---|---|
Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Male; Treatment Outcome | 2000 |
[The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome].
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Cyclosporine; Danazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisone; Recurrence; Treatment Outcome | 2001 |
26 other study(ies) available for danazol and cyclosporine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
[Drugs and other substances inducing hypertension].
Topics: Antidepressive Agents, Tricyclic; Contraceptives, Oral; Cyclosporine; Danazol; Erythropoietin; Extracellular Space; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Hypertension; Monoamine Oxidase Inhibitors; Recombinant Proteins; Sodium, Dietary | 1992 |
Pharmacokinetics of cyclosporin during administration of danazol.
Topics: Cyclosporine; Danazol; Drug Interactions; Humans; Metabolic Clearance Rate; Middle Aged | 1994 |
Interaction between cyclosporine and danazol in a pediatric patient.
Topics: Anemia, Aplastic; Child; Cyclosporine; Danazol; Drug Interactions; Estrogen Antagonists; Humans; Immunosuppressive Agents; Male | 1996 |
Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Danazol; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukins; Methylprednisolone Hemisuccinate; Plasma Exchange; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Vincristine | 1996 |
Immunosuppressive drug therapy.
Topics: Animals; Cats; Cyclosporine; Danazol; Dogs; Immunosuppressive Agents | 1996 |
Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Danazol; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Recombinant Proteins | 1996 |
[Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
Topics: Adult; Anemia, Aplastic; Chromosomes, Human, Pair 7; Cyclosporine; Danazol; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Monosomy; Myelodysplastic Syndromes | 1997 |
Salvage therapy and long-term remission with danazol and cyclosporine in refractory Evan's syndrome.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Cyclosporine; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Humans; Immunosuppressive Agents; Male; Purpura, Thrombocytopenic; Remission Induction; Salvage Therapy; Syndrome | 1999 |
Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia.
Topics: Anemia, Aplastic; Cyclosporine; Danazol; Endometriosis; Estrogen Antagonists; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Liver Failure, Acute; Middle Aged | 2001 |
Improved understanding of the effect of food on drug absorption and bioavailability for lipophilic compounds using an intestinal pig perfusion model.
Topics: Animals; Biological Availability; Cyclosporine; Danazol; Food; Intestinal Absorption; Jejunum; Particle Size; Perfusion; Solubility; Swine | 2008 |
Novel milk-based oral formulations: proof of concept.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Buffers; Chemistry, Pharmaceutical; Cyclosporine; Danazol; Ethanol; Humans; Male; Meloxicam; Milk; Solubility; Thiazines; Thiazoles | 2010 |
Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Danazol; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Child; Child, Preschool; Clonal Evolution; Cyclosporine; Danazol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Levamisole; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Danazol increases T regulatory cells in patients with aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Danazol; Female; Humans; Male; Middle Aged; Prospective Studies; T-Lymphocytes, Regulatory | 2018 |